Is Stage 2 kidney cancer considered early stage?

Written by Wang Jian
Urology
Updated on March 19, 2025
00:00
00:00

Kidney cancer refers to a malignant tumor that occurs in the kidney. The causes of kidney cancer are not particularly clear at present, but are related to genetics, smoking, obesity, hypertension, and the treatment of hypertension. Most early-stage kidney cancer patients are found to have asymptomatic kidney cancer during health check-ups, and these patients account for more than 50% to 60% of all kidney cancer cases.

Patients with kidney cancer generally experience back pain and hematuria, and some patients may present with an abdominal mass. Stage II kidney cancer is considered early-stage kidney cancer. For the treatment of kidney cancer, a clear diagnosis first requires a CT scan and enhanced CT of the kidney. The preferred treatment method for stage II kidney cancer is radical nephrectomy, which can be performed using laparoscopic surgery or traditional open surgery, with laparoscopic surgery primarily favored at present.

After kidney cancer surgery, regular follow-ups are necessary to prevent distant metastasis. Therefore, post-operative check-ups should occur every 3 to 6 months for the first three years, followed by an annual follow-up thereafter. Hence, stage II kidney cancer, being early-stage, can be cured.

Other Voices

doctor image
home-news-image
Written by Wang Jian
Urology
54sec home-news-image

Can kidney cancer that has spread to the lungs be cured?

Kidney cancer usually reaches an advanced stage by the time it metastasizes to the lungs, leading to a generally low survival rate. For early and intermediate-stage kidney cancer patients, surgical treatment is typically employed. However, in advanced stages, especially when there are lung metastases, surgical methods are often not suitable. However, if the metastatic foci are small, it is still recommended to remove them surgically. Immunotherapy can be used for lung metastases, such as using interferon or targeted therapy. Targeted therapy tends to be effective, commonly using drugs like sorafenib and sunitinib for first-line or second-line treatment of metastatic kidney cancer. Although a complete cure is not possible, these treatments can significantly prolong the patient's lifespan, improve survival rates, and alleviate symptoms.

doctor image
home-news-image
Written by Zou De Bo
Urology
43sec home-news-image

Kidney cancer thrombus

Tumor thrombus is one of the common complications of tumors, and refers to cancer cells in blood vessels or lymphatic vessels similar to blood clots, i.e., cancer cells clustering together, invading the vessels, and causing abnormalities in blood coagulation function, leading to disorders in blood circulation and abnormal coagulation with clustered cancer cells. Generally, the risk of tumor thrombus formation is very high, and patients with tumor thrombus have much worse treatment outcomes than those without. Renal cancer is also a tumor commonly associated with tumor thrombus. Once a tumor thrombus occurs, it indicates that the surgery might be staged quite late, and thus, its treatment results are also relatively poor.

doctor image
home-news-image
Written by Li Yuan Wei
Urology
1min 12sec home-news-image

What are the characteristics of hematuria in renal cancer?

What we commonly refer to as kidney cancer actually includes two aspects. One is renal cell carcinoma, and the other is renal pelvis cancer or ureteral cancer. The characteristics of hematuria are different in these two types. Renal cell carcinoma, simply understood, grows inside the kidney and is not connected with urine. Only when the kidney tumor grows large enough to breach the kidney or renal pelvis will the tumor rupture and bleed, causing hematuria. This generally occurs in the middle to late stages of kidney cancer. On the other hand, renal pelvis cancer or ureteral cancer exhibits intermittent hematuria in the early stages without significant symptoms, but as it progresses to the middle and late stages, symptoms like kidney hydronephrosis and hematuria slowly appear. When diagnosing these conditions, any occurrence of hematuria must be investigated to determine the cause. Initial screening can be done using urinary system ultrasound, urinalysis, or routine urine tests. More precise methods include enhanced CT or MRI of the urinary system, which facilitate easier diagnosis.

doctor image
home-news-image
Written by Zou De Bo
Urology
1min 20sec home-news-image

Post-nephrectomy care for renal cancer

Postoperative care measures for kidney cancer primarily include observing the patient's vital signs. After a radical nephrectomy for a large renal tumor, a significant amount of tissue is removed including the kidney, surrounding adrenal fat, and lymph nodes at the renal hilum, which results in larger surgical wounds and potentially more bleeding. Therefore, it is crucial to closely monitor for signs of bleeding and ensure that transfusions and fluid administrations are unobstructed. Secondly, careful observation and management of the wound drainage tubes are required. Thirdly, for radical nephrectomies, once the patient is past the anesthesia phase and the blood pressure is stable, a semi-reclined position can be adopted. Patients who have undergone partial nephrectomy should remain in bed for one to two weeks to prevent further bleeding, and kidney functions should be monitored. Additionally, attention should be paid to symptoms such as breath holding and difficulty in breathing. Postoperative feeding should commence once gastrointestinal function is restored; thereafter, nutrition should be enhanced to boost bodily resistance. Calming medications may be appropriately used to ease pain, facilitating movement, effective coughing, and expectoration.

doctor image
home-news-image
Written by Zhou Qi
Nephrology
46sec home-news-image

Can kidney cancer patients eat eggs?

Patients with kidney cancer can eat eggs. Kidney cancer is a malignant tumor of the kidney, originating from the epithelial cells of the renal tubules. Although this disease is a malignant tumor, the patient's body still needs nutrients. Therefore, high-protein foods can be consumed by patients, and they should maintain a protein intake roughly the same as that of healthy individuals. Eggs are rich in protein, with each egg containing about seven to eight grams of protein. Kidney cancer patients can eat eggs without worsening their condition or causing the disease to spread. The folk saying that some foods are "stimulating" is not scientifically founded. Currently, there is no clear evidence in medicine to support the claim that eggs and beef are "stimulating."